Amalia Ruiz

Lecturer in Biochemistry & Pharmacology

University of Bradford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Tissue Engineering Tissue Engineering professors in United Kingdom

Contact this professor

ORCID

Google Scholar

Academic Page

About

Amalia Ruiz is a Lecturer in Biochemistry & Pharmacology at the University of Bradford, UK. Her research focuses on innovative therapies for cancer treatment, including the development of targeted nanoparticles, magnetic drug delivery systems, and liposomal formulations. Recent publications highlight her work on applications of nanomaterials for combination therapies, particularly in models of triple-negative breast cancer and prostate cancer.

Amalia Ruiz

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

CD-44 targeted nanoparticles for combination therapy in an in vitro model of triple-negative breast cancer: Targeting the tumour inside out

Piezoelectric Nanomaterials for Cancer Therapy: Current Research and Future Perspectives on Glioblastoma

Magnetically induced drug release from niosome-based nanocarriers loaded with doxorubicin

Oligo(styryl)benzenes liposomal AIE-dots for bioimaging and phototherapy in an in vitro model of prostate cancer

Encapsulation and Delivery of Mitoxantrone Using Zirconium-Based Metal–Organic Frameworks (MOFs) and Their Cytotoxic Potential in Breast Cancer Cells

Insight into the liposomal encapsulation of mono and bis-naphthalimides

Co-Loading of Black Phosphorus Nanoflakes and Doxorubicin in Lysolipid Temperature-Sensitive Liposomes for Combination Therapy in Prostate Cancer

Design of a graphene oxide-BODIPY conjugate for glutathione depletion and photodynamic therapy

PD1 blockade potentiates the therapeutic efficacy of photothermally-activated and MRI-guided low temperature-sensitive magnetoliposomes

Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids

Does black phosphorus hold potential to overcome graphene oxide? A comparative review of their promising application for cancer therapy

Does black phosphorus hold potential to overcome graphene oxide? A comparative review of their promising application for cancer therapy

Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo

Multifunctional nanoassemblies target bacterial lipopolysaccharides for enhanced antimicrobial DNA delivery

Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo.

Encapsulated doxorubicin crystals influence lysolipid temperature-sensitive liposomes release and therapeutic efficacy in vitro and in vivo

Toxicological evaluation of highly water dispersible few-layer graphene in vivo

Collaborators (10)

Sanjit Nayak

Jacobo Elies

Alejandro Marin-Menendez

Thomas Swift

Cécilia Ménard‐Moyon

Philip Drake

Klaus Pors

Stephen Meech

Christopher Morris

Barbara Richichi

How do I reach out?

Meet Kite AI